Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy.

Abstract

Juvenile nasopharyngeal angiofibroma (JNA) is a disease of adolescent males characterised by high vascularity with local aggressiveness. This analysis was intended to see the effectiveness of radiation in locally advanced JNA. We included patients treated from 1990-2012. A total of 31 patients met study criteria. Median age was 16 years (range: 12-33 years). Radiation was used for refractory, residual or unresectable locally advanced disease. The median radiation dose was 30 Gy (range: 30-45 Gy). Median follow-up was 36 months (Range: 1-271 months). The median progression-free survival [PFS] was not reached. PFS at 3, 5 and 10 years was 91.7, 70.7 and 70.7% respectively. Three patients progressed at 38, 43 and 58 months after completion of treatment and opted for alternative therapy. One patient developed squamous cell carcinoma of the nasal ale 15 years after radiation.

• Authors: S Mallick, R Benson, S Bhasker, B K Mohanti
• Journal: Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale (Acta Otorhinolaryngol Ital) Vol. 35 Issue 2 Pg. 75-9 (Apr 2015) ISSN: 1827-675X [Electronic] Italy
• PMID: 26019389 (Publication Type: Journal Article)

Topics

• Adolescent
• Adult
• Angiofibroma (radiotherapy)
• Child
• Humans
• Male
• Nasopharyngeal Neoplasms (radiotherapy)
• Retrospective Studies
• Time Factors
• Treatment Outcome
• Young Adult